SciELO - Scientific Electronic Library Online

 
vol.23 número12Enfermedad tromboembólica venosa: análisis de 239 casosEstudio de utilización de Tenofovir DF en el tratamiento antirretroviral de gran actividad índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Anales de Medicina Interna

versão impressa ISSN 0212-7199

Resumo

BATUECAS MOHEDANO, M.; CARBALLO ALVAREZ, F.  e  GARCIA MENENDEZ, L.. Follow-up of serum monoclonal gammopathy at Guadalajara Health Area. An. Med. Interna (Madrid) [online]. 2006, vol.23, n.12, pp.569-572. ISSN 0212-7199.

Objective: To study the clinical course of patients with a serum monoclonal protein at Guadalajara Health Area. Material and methods: Prospective study of 186 patients with a newly diagnosed monoclonal component. They have been collected during the years 1999 and 2000. Results: The cumulative transformation probability at 43 months was 4.99% for those patients whose monoclonal gammopathy was overlooked, and 2% at 23 months for patients with monoclonal gammopathy of undetermined significance. The cumulative probability of survival for patients with multiple myeloma was 66.7% at 21 months. The conditional mortality rate (patients/months) at 4 years due to haematological disease was 4.48x10-4 for overlooked patients, 0 for diagnosed of monoclonal gammopathy of undetermined significance and 1.388x10-2 for multiple myeloma diagnosed. Discussion: A non malignant M component must be followed up due to it could increase patients' survival rate in relation with transformation in malignant disease.

Palavras-chave : Monoclonal gammopathy; Plasma cells dyscrasias; Electrophoresis; Multiple myeloma; Waldenström macroglobulinemia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons